Linda Elsegood delivers her presentation on Low Dose Naltrexone (LDN) as part of the LDN Book Volume 2 Tour which took place virtually in October 2020. Hosted by Madison Drugs.

Linda is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of The LDN Book Volumes 1 and 2. Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future. Through the Trust, she has connected thousands of patients, doctors, and pharmacists around the world with information, articles, and patient stories about LDN.